U.s. Food And Drug Administration, News
U.s. food and drug administration, Latest News
The United States Food and Drug Administration is a Federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods & feed and veterinary products.
US President Biden gets COVID-19 vaccine booster shot
US President Joe Biden received his COVID-19 vaccine booster shot on Monday afternoon (local time) at the White House. ...
Pfizer to soon submit data on Covid vax for kids aged 5-11
Washington, Sep 27 Pfizer is soon expected to submit data to the US Food and Drug Administration (FDA) ... ...
Covid will end with Delta, to continue as endemic risk: Ex-FDA chief
Washington, Sep 24 The current wave of Covid-19 cases, driven by the Delta variant, is going to be ... ...
US FDA okays Covid booster shot for people above 65, or at high-risk
Washington, Sep 23 The US Food and Drug Administration (FDA) has authorised booster shots of the Pfizer Covid-19 ... ...
US FDA authorizes Pfizer's Covid booster shots for elderly, high-risk Americans
US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk. ...
J&J says Covid booster shot shot 94% effective
Washington, Sep 21 Johnson & Johnson on Tuesday announced that its booster shot, given two months after the ... ...
Booster shot debated in US amid Covid resurgence
Washington, Sep 18 A booster shot against Covid-19 was debated in the US as the country is witnessing ... ...
US FDA: No Pfizer booster shots for 16 and above, approved only for people over 65
The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all ...